Zenuzolac (VGX-1027) is under development for the treatment of severe pneumonitis caused by Coronavirus Disease 2019 (COVID-19), inflammatory diseases and diabetic nephropathy. The drug candidate is ...
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with non-steroidal anti-inflammatory compounds and opioids that lack efficacy and that are associated with ...